NCT06984159 2025-05-22
The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3 Completed